Director, Quality Assurance
ICON plc
Summary
As a Director, Quality Assurance at ICON, you will ensure the quality and compliance of clinical trials, interpret regulatory requirements, and contribute to the advancement of innovative treatments and therapies.
Job description
What You Will Do
Your focus will be on driving quality assurance and compliance performance, ensuring quality, and building capability across your area (specifically Imaging and Cardiac Services).
- Serving as the QA business partner to Medical Imaging and Cardiac Services leadership and teams, providing strategic guidance on quality, regulatory compliance, and emerging risk.
- Leading the development and implementation of quality assurance strategies and processes to support clinical trial activities including establishing quality priorities with leadership and integrating quality considerations into business and operational planning.
- Conducting comprehensive quality assessments and audits to ensure compliance with regulatory standards and guidelines.
- Collaborating with cross-functional teams to identify and address quality issues and implement corrective actions as needed; analyzing quality trends to identify systemic risk and preventive improvement opportunities.
- Providing expert guidance and support to staff regarding quality assurance policies, procedures, and best practices.
- Contributing to the continuous improvement of quality management systems and documentation. Promote a proactive culture of quality and continuous improvement.
- Establish quality priorities with IMC leadership and integrate quality considerations into business and operational planning.
- Provide strategic oversight of the risk-based IMC audit program, including internal and vendor audits.
- Represent Quality & Compliance in strategic sponsor relationships, governance, and significant quality escalations. Support the development, interpretation, and governance of quality agreements.
Your Profile
You will bring significant quality assurance and compliance experience, with a track record of building high-performing teams and delivering results.
Requirements
- Bachelor's degree in Life Sciences, Pharmacy, or related field; advanced degree preferred
- Minimum of 10 years of experience in quality assurance within the pharmaceutical, biotechnology, Medical Imaging or CRO industry, with significant experience in a leadership role
- Extensive knowledge of regulatory requirements and guidelines governing clinical trials (e.g., ICH-GCP, FDA regulations)
- Knowledge of AI governance and regulations is advantageous
- Strong analytical and problem-solving skills, with the ability to identify and resolve complex quality issues
- Excellent communication and interpersonal skills, with the ability to collaborate effectively with cross-functional teams and stakeholders
- Strong leadership skills including cross functional management
- Willingness to travel as required (approximately 25%)
Benefits
- Competitive base salary
- Performance related incentives
- Medical, Dental & Vision
- Retirement and pension plans
- Life assurance
- Disability coverage
- Employee assistance programmes
- Wellbeing resources
- Learning and development opportunities
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.